Literature DB >> 15265809

The NAADP receptor: commentary on Billington et al.

A Galione1, J Parrington, J Dowden.   

Abstract

NAADP is a recently described calcium-mobilizing messenger. First discovered as a potent calcium-releasing molecule in sea urchin eggs, its actions have now been reported in several mammalian cell types. In the sea urchin egg, NAADP-sensitive calcium release channels appear distinct from inositol trisphosphate or ryanodine receptors, and are mainly localized to acidic compartments. In this study, Billington et al. extend the pharmacology of the putative NAADP receptor utilizing molecules unrelated to NAADP itself. This work may provide an important step in developing selective NAADP receptor modulators that will help define the role of NAADP in cell signalling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265809      PMCID: PMC1575195          DOI: 10.1038/sj.bjp.0705888

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Two different but converging messenger pathways to intracellular Ca(2+) release: the roles of nicotinic acid adenine dinucleotide phosphate, cyclic ADP-ribose and inositol trisphosphate.

Authors:  J M Cancela; O V Gerasimenko; J V Gerasimenko; A V Tepikin; O H Petersen
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  NAADP receptors are present and functional in the heart.

Authors:  J Bak; R A Billington; G Timar; A C Dutton; A A Genazzani
Journal:  Curr Biol       Date:  2001-06-26       Impact factor: 10.834

3.  Unique kinetics of nicotinic acid-adenine dinucleotide phosphate (NAADP) binding enhance the sensitivity of NAADP receptors for their ligand.

Authors:  S Patel; G C Churchill; A Galione
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Two neuropeptides recruit different messenger pathways to evoke Ca2+ signals in the same cell.

Authors:  D Burdakov; A Galione
Journal:  Curr Biol       Date:  2000-08-24       Impact factor: 10.834

Review 5.  Coordination of Ca2+ signalling by NAADP.

Authors:  S Patel; G C Churchill; A Galione
Journal:  Trends Biochem Sci       Date:  2001-08       Impact factor: 13.807

6.  Characterization of NAADP(+) binding in sea urchin eggs.

Authors:  R A Billington; A A Genazzani
Journal:  Biochem Biophys Res Commun       Date:  2000-09-16       Impact factor: 3.575

7.  Spatial control of Ca2+ signaling by nicotinic acid adenine dinucleotide phosphate diffusion and gradients.

Authors:  G C Churchill; A Galione
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

8.  Unique inactivation properties of NAADP-sensitive Ca2+ release.

Authors:  A A Genazzani; R M Empson; A Galione
Journal:  J Biol Chem       Date:  1996-05-17       Impact factor: 5.157

9.  Nicotinic acid adenine dinucleotide phosphate (NAADP(+)) is an essential regulator of T-lymphocyte Ca(2+)-signaling.

Authors:  I Berg; B V Potter; G W Mayr; A H Guse
Journal:  J Cell Biol       Date:  2000-08-07       Impact factor: 10.539

10.  Functional visualization of the separate but interacting calcium stores sensitive to NAADP and cyclic ADP-ribose.

Authors:  H C Lee; R Aarhus
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

View more
  2 in total

1.  Analogues of the nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist Ned-19 indicate two binding sites on the NAADP receptor.

Authors:  Daniel Rosen; Alexander M Lewis; Akiko Mizote; Justyn M Thomas; Parvinder K Aley; Sridhar R Vasudevan; Raman Parkesh; Antony Galione; Minoru Izumi; A Ganesan; Grant C Churchill
Journal:  J Biol Chem       Date:  2009-10-13       Impact factor: 5.157

2.  Identification of a chemical probe for NAADP by virtual screening.

Authors:  Edmund Naylor; Abdelilah Arredouani; Sridhar R Vasudevan; Alexander M Lewis; Raman Parkesh; Akiko Mizote; Daniel Rosen; Justyn M Thomas; Minoru Izumi; A Ganesan; Antony Galione; Grant C Churchill
Journal:  Nat Chem Biol       Date:  2009-02-22       Impact factor: 15.040

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.